Tracing Ascent Capital’s returns from partial exit in drug ingredients maker
Advertisement

Tracing Ascent Capital’s returns from partial exit in drug ingredients maker

By Ankit Doshi

  • 22 Oct 2020
Premium
Tracing Ascent Capital’s returns from partial exit in drug ingredients maker
Credit: 123RF.com

Homegrown private equity firm Ascent Capital appears to have scored neat returns from a partial exit...

This is a Premium article, Subscribe to read the full story!

Limited Time Offer - Subscribe now & get free access to The Unicorn report.

The year 2021 was a record year for Unicorn activity in India, with 47 new Unicorns being added to the list, from a previous 11 in 2020. Get access to exclusive analysis on growth landscape, sectoral view, future Unicorns & more..

Advertisement
Advertisement